William J. Ince

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

Oligoprogressive renal cell carcinoma: What is the role of surgery?

Oligoprogressive renal cell carcinoma: What is the role of surgery?

Journal: BJU international

Published: April 13, 2026

Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.

Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.

Journal: Frontiers in artificial intelligence

Published: January 26, 2026

Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.

Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.

Journal: The Lancet. Oncology

Published: December 25, 2025

Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.

Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.

Journal: Oral oncology

Published: October 09, 2025

'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.

'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.

Journal: BJU international

Published: July 17, 2024

Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.

Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.

Journal: Future oncology (London, England)

Published: June 18, 2024

A systematic review of ongoing clinical trials in optic pathway gliomas.

A systematic review of ongoing clinical trials in optic pathway gliomas.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: April 22, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026